Leukotriene B4-induced neutrophil extracellular traps impede the clearance of Pneumocystis

Eur J Immunol. 2024 May;54(5):e2350779. doi: 10.1002/eji.202350779. Epub 2024 Mar 5.

Abstract

Pneumocystis pneumonia (PCP) is a fungal pulmonary disease with high mortality in immunocompromised patients. Neutrophils are essential in defending against fungal infections; however, their role in PCP is controversial. Here we aim to investigate the effects of neutrophil extracellular traps (NETs) on Pneumocystis clearance and lung injury using a mouse model of PCP. Intriguingly, although neutrophils play a fundamental role in defending against fungal infections, NETs failed to eliminate Pneumocystis, but instead impaired the killing of Pneumocystis. Mechanically, Pneumocystis triggered Leukotriene B4 (LTB4)-dependent neutrophil swarming, leading to agglutinative NET formation. Blocking Leukotriene B4 with its receptor antagonist Etalocib significantly reduced the accumulation and NET release of neutrophils in vitro and in vivo, enhanced the killing ability of neutrophils against Pneumocystis, and alleviated lung injury in PCP mice. This study identifies the deleterious role of agglutinative NETs in Pneumocystis infection and reveals a new way to prevent NET formation, which provides new insights into the pathogenesis of PCP.

Keywords: Fungal; Leukotriene B4; Lung injury; Neutrophil extracellular trap; Pneumocystis pneumonia.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Disease Models, Animal
  • Extracellular Traps* / immunology
  • Humans
  • Leukotriene B4* / immunology
  • Leukotriene B4* / metabolism
  • Mice
  • Mice, Inbred C57BL
  • Neutrophils* / immunology
  • Pneumocystis* / immunology
  • Pneumonia, Pneumocystis* / immunology

Substances

  • Leukotriene B4